Avant Technologies, Inc, and its JV partner, Ainnova Tech, a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence announced the companies are in talks with an international healthcare innovation company to license or potentially acquire its patented early disease detection technology. If successful, it’s a global license or acquisition that has the potential to revolutionize preventive health reporting and to generate correlations for future detection of new diseases without the need for all the patient’s data.
Health Technology Insights: Prolucent Appoints Staci Roberts as Chief Executive Officer
Avant and Ainnova continue to grow the footprint and capabilities of their technology portfolio with the goal of being a leader in early disease detection using the Company’s signature AIdriven Vision AI technology platform.
Vinicio Vargas, Chief Executive Officer at Ainnova and member of the Board of Directors of the joint venture company, Ai-nova Acquisition Corp., said of the Company’s aim to continue to add to its portfolio, “Our purpose is to create the future of early disease detection in an accessible way, so that patients can get a preventive check-up anywhere, at a low cost, and easily. We want to prevent patients with risk factors from developing other diseases that could have been avoided before they became a real problem.
Health Technology Insights: FDA Grants Interchangeable Designation to Fresenius Kabi’s biosimilar Otulfi
“To this end, we are seeking to integrate new technologies into our portfolio within a single platform, both through our R&D efforts and through potential exclusive licenses or acquisitions.”
Avant and Ainnova see the retina as a new vital sign, but also understand that leveraging the results of laboratory tests and basic patient data can all work in concert to provide a comprehensive health report.
Vargas added, “We have already integrated an exclusive license for four algorithms into our Vision AI platform, and we are now in talks to license and potentially acquire an innovative technology that would be a game changer in our industry.”
Avant will inform its shareholders of any updates at an appropriate time.
Health Technology Insights: Albertsons Companies Pharmacies Welcomes Rite Aid Customers and Employees
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
